Status:
COMPLETED
Residual Risk Assessment Of HIV Transmission
Lead Sponsor:
French National Agency for Research on AIDS and Viral Hepatitis
Conditions:
HIV Infection
Eligibility:
MALE
18-65 years
Phase:
NA
Brief Summary
The main objective of this one year multidisciplinary research is to estimate the frequency of seropositive men having sex with men (MSM) under antiretroviral therapy (ART) having an undetectable bloo...
Detailed Description
The secondary objective is to characterize the biological and behavioral components that might influence VL discordance between blood and semen. Background: In most cases the semen VL reflects the bl...
Eligibility Criteria
Inclusion
- Age ≥ 18 and
- Able to give written consent
- Covered by French Social Security
- be a men and have sex with men
- be treated with the same ARV treatment for at least 3 months
- blood plasma have a CV undetectable (\<50 copies / ml) for at least 6 months
- accept the constraints imposed by the study, that is to say one or more masturbation in hospital
Exclusion
- Under protection(saving) of justice
Key Trial Info
Start Date :
July 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2012
Estimated Enrollment :
167 Patients enrolled
Trial Details
Trial ID
NCT01413152
Start Date
July 1 2011
End Date
March 1 2012
Last Update
December 27 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jade Ghosn
Le Kremlin-Bicêtre, France